Dr. Matthias Rose, Professor and Chair of the Department of Psychosomatic Medicine at Charité - Universitätsmedizin Berlin discusses the integration of patient-reported outcomes in the CONVINCE study.
By combining clinical and patient-reported end points, the CONVINCE trial is unique and affords opportunities for improving patient health status and treatment goals.
Krister Cromm, Fresenius Medical Care’s Director Person-Centered Outcomes Research, discuss the company’s evolution from disease-centered to person-centered integrated trial design.
David Rhew, Microsoft’s Chief Medical Officer and Vice President of Healthcare, discusses ChatGPT’s uses in healthcare.
Dr. Brigitte Schiller, Fresenius Medical Care’s senior vice president for home therapies, discusses the ecosystem and opportunities for patients to do dialysis in their own home.
Dr. Frank Maddux discusses the potential impact of GLP-1 Receptor agonists and SGLT-2 Inhibitors on chronic kidney disease care.
Dr. Matthias Rose, Professor and Chair of the Department of Psychosomatic Medicine at Charité - Universitätsmedizin Berlin discusses the integration of patient-reported outcomes in the CONVINCE study.
Investigators from Wake Forest University and the Renal Research Institute are conducting a study, funded by PCORI, to find out if an incremental HD treatment plan is safe and beneficial to patients with residual kidney function. Jochen Raimann, the director of data analytics for the Renal Research Institute, discusses the study and its potential benefits for patients.
Dr. Isaac “Zak” Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School discusses the adoption of artificial intelligence and machine learning in healthcare.
Dr. Dr. Vivekanand Jha, Executive Director, of The George Institute for Global Health in India discusses health inequality and how it manifests in communities.
A growing body of evidence demonstrates that connected health technologies make healthcare more effective and efficient. Connected health delivers many benefits including expanded access to care, safety, better disease management, improved medication adherence, and reduced hospitalizations and readmissions. Dr. Shelly Nash Senior Vice President and Chief Medical Information Officer
for the Global Medical Office at Fresenius Medical Care discusses the benefits of connected health.
Prof. Peter Blankestijn discusses the results of the multi-center CONVINCE Study including how the use of hemodiafiltration impacts patient morbidity and all-cause mortality as well as patient-reported outcomes. The results were presented at the ERA EDTA conference in June of 2023.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io